US Merger & Acquisition SEC Filings — March 31, 2026

31-03-2026

Cyabra, Inc. (f/k/a Trailblazer Holdings, Inc.) completed its previously announced business combination with Trailblazer Merger Corporation I, a blank-check SPAC, approved by stockholders on February 18, 2026, with closing on March 27, 2026. The combined company, operating as Cyabra, Inc. under CEO Dan Brahmy, expects its common stock to begin trading on Nasdaq under ticker 'CYAB' on March 27, 2026, while Trailblazer's prior tickers 'TMBC' and 'TMBCR' will cease trading. This positions Cyabra as the first publicly traded company dedicated to fighting disinformation by analyzing online manipulation.

• ·Stockholder approval at special meeting: February 18, 2026
• ·Legal advisors to Cyabra: Lowenstein Sandler LLP, Goldfarb Gross Seligman; Financial advisor: LifeSci Capital
• ·Legal advisors to Trailblazer: Loeb & Loeb LLP, Sullivan & Worcester LLP
• ·Cyabra website: www.cyabra.com; Trailblazer website: www.trailblazermergercorp.com

31-03-2026

SCYNEXIS, Inc. (NASDAQ: SCYX) announced the completion of its acquisition of SCY-770 (formerly PXL-770), a clinical-stage oral AMPK activator from Poxel S.A., for an upfront payment of $8M plus up to $8M in development milestones and $180M in commercial milestones to treat ADPKD. The company plans to initiate a Phase 2 proof-of-concept study in Q4 2026 with an early efficacy readout in 2H 2027, strengthening its rare disease pipeline alongside antifungal assets like BREXAFEMME (licensed to GSK) and SCY-247. SCY-770 has Orphan Drug Designation and a favorable safety profile from eight prior clinical trials, targeting a U.S. market of 140,000 ADPKD patients.

• ·SCY-770 evaluated in eight clinical trials with favorable safety profile and Orphan Drug Designation by FDA.
• ·Conference call scheduled for March 31, 2026 at 8:30 a.m. ET (U.S. Dial-in: 1-877-704-4453; International: 201-389-0920; Conference ID: 13759746).
• ·SCY-247 Phase 1 IV data expected Q3 2026; has QIDP, Fast Track, and Orphan Drug designations.
• ·BREXAFEMME outlicensed to GSK with low-to-mid single-digit royalties.

31-03-2026

BrightSpring Health Services, Inc. (NASDAQ: BTSG) completed the sale of its ResCare Community Living business to Sevita on March 31, 2026, following the definitive agreement announced in January 2025. The divestiture enables BrightSpring to focus on its Provider Services division, comprising Home Health Care, Personal Care, and Rehab Therapy services, while Sevita integrates the business to expand its community services. No financial terms of the transaction were disclosed in the filing.

• ·Definitive agreement for the sale was first announced in January 2025.
• ·BrightSpring provides services in all 50 states.
• ·Sevita operates in 40 states.

31-03-2026

On March 25, 2026, Oramed Pharmaceuticals Inc. completed the sale of its wholly-owned subsidiary Oratech Pharma, Inc. to Lifeward Ltd. under a Share Purchase Agreement, receiving 1,250,363 Lifeward Ordinary Shares, 1,006,113 Pre-Funded Warrants (exercise price $0.0001 per share), Share Purchase Warrants for up to 1,296,296 shares (initial exercise $5.40), and 4% revenue sharing on Lifeward's ReWalk Personal Exoskeleton net revenues until the earlier of 10 years, reaching a maximum amount, or Lifeward's market cap hitting $200 million. Concurrently, Oramed closed a $9 million private placement purchase of senior secured convertible notes from Lifeward (initial conversion $5.40) plus warrants for 1,666,666 shares (initial exercise $5.40). No declines or flat performance metrics reported in this transactional update.

• ·Revenue sharing payments end at earliest of 10 years post-closing, receipt of undefined Maximum Amount, or Lifeward market cap >= $200 million.
• ·Notes and warrants have adjustment provisions; initial prices $5.40 per share.
• ·Transaction initially announced January 12, 2026; prior 8-K filed January 14, 2026.

31-03-2026

Spire Inc. completed its acquisition of the Piedmont Natural Gas business in Tennessee from Duke Energy for $2.48 billion, effective March 31, 2026, expanding its regulated utility footprint and establishing Spire Tennessee as the largest investor-owned natural gas utility in the state, serving more than 200,000 customers across nearly 3,800 miles of pipelines. More than 200 Piedmont employees transitioned to Spire, with additional roles to be added, supporting a seamless integration. The deal aligns with Spire’s long-term adjusted EPS growth target of 5-7% and represents approximately 20% of its capital investment plan through 2030.

• ·Joe Hampton appointed president of Spire Tennessee.
• ·BMO Capital Markets Corp. acted as exclusive financial advisor to Spire.

31-03-2026

Soulpower Acquisition Corporation (NYSE:SOUL) and SWB Holdings amended their Business Combination Agreement, adding an acquisition of Uruguay Iron Mine with approximately 1,170 million tons of estimated resources while eliminating certain other assets from contributions, resulting in a pro forma combined company valuation of approximately $8.5 billion assuming no redemptions and $10/share valuation. The amendment includes procedural updates and was unanimously approved by Soulpower's board and special committee. Closing is now anticipated in late Q2 or Q3 2026, later than the original November 2025 announcement, subject to shareholder approval, regulatory conditions, and customary closing requirements.

• ·Soulpower IPO underwritten by Cantor Fitzgerald in April 2025
• ·Confidential draft Form S-4 submitted December 30, 2025; public filing expected Q2 2026
• ·Pubco Class A Ordinary Shares to list on NYSE under ticker SOUL post-closing
• ·SOUL WORLD BANK™ banking license pending BVI regulatory and Court approvals
• ·Certain excluded assets may be considered for post-closing acquisition by Pubco

31-03-2026

Spartacus Acquisition Corp. II, a blank check company (SPAC) targeting technology, media, and telecommunications sectors, announced on March 31, 2026, that commencing April 2, 2026, holders of its units (TMTSU) may elect to separately trade Class A Ordinary Shares (TMTS) and redeemable Warrants (TMTSW) on the Nasdaq Global Market. No fractional Warrants will be issued upon separation, and unsegregated units will continue trading as TMTSU. This enhances liquidity for shareholders without any reported declines or flat performance in operations.

• ·Company address: 3800 N Lamar Blvd, Suite 200, Austin, TX 78756
• ·Company focuses on merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with technology, media and telecommunications companies
• ·Brokers must contact Continental Stock Transfer & Trust Company to separate units

31-03-2026

Inflection Point Acquisition Corp. VI priced its initial public offering of 22,000,000 units at $10.00 per unit, raising $220 million, with units to trade on Nasdaq under IPFXU starting March 27, 2026. Each unit includes one Class A ordinary share and one-third of a redeemable warrant exercisable at $11.50 per share, and the offering is expected to close on March 30, 2026, subject to customary conditions. Underwriters Cantor Fitzgerald & Co. and Academy Securities, Inc. have a 45-day option to purchase up to 3,300,000 additional units for over-allotments.

• ·S-1 registration statement (File No. 333-292443) declared effective by SEC on March 26, 2026
• ·Company targets North American or European businesses in disruptive growth sectors
• ·Ticker symbols: IPFXU (units), IPFX (shares), IPFXW (warrants) post-separation

31-03-2026

On March 31, 2026, Teamshares Inc. hosted an Investor Day in connection with the proposed business combination with Live Oak Acquisition Corp. V, during which an investor presentation was made available (furnished as Exhibit 99.1). The filing provides Regulation FD disclosure but contains no specific financial metrics, results, or period-over-period comparisons. Standard forward-looking statements and risk factors related to the merger are included, such as potential termination risks and shareholder approval requirements.

• ·Filing date: March 31, 2026
• ·Securities traded on Nasdaq: LOKVU (units), LOKV (shares), LOKVW (warrants)
• ·Principal executive offices: 4921 William Arnold Road, Memphis, TN 38117
• ·Post-merger ticker reference: NASDAQ: TMS

31-03-2026

Mobivity Holdings Corp. amended its Restated Articles of Incorporation (Item 5.03) to authorize 200,000,000 shares of common stock and 150,000,000 shares of Non-Voting Preferred Stock, both with a par value of $0.001 per share, as part of an acquisition/disposition completion (Item 2.01), unregistered equity sales (Item 3.02), and related exhibits (Item 9.01). The Non-Voting Preferred Stock lacks voting rights except as required by Nevada law and includes an anti-dilution conversion feature where the conversion price adjusts to the per-share price of the first post-issuance common stock offering of at least $5,000,000 aggregate.

• ·Non-Voting Preferred Stock is identical to Common Stock except for voting rights denial under NRS 78.2055, 78.207, 78.390 and single anti-dilution adjustment on first qualifying $5M common issuance.
• ·Par value of $0.001 per share for both Common Stock and Non-Voting Preferred Stock.